ID

34178

Description

VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT02392455

Lien

https://clinicaltrials.gov/show/NCT02392455

Mots-clés

  1. 15/01/2019 15/01/2019 -
  2. 14/05/2019 14/05/2019 -
Détendeur de droits

GSK group of companies

Téléchargé le

15 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455

Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18 or older
Description

ID.1

Type de données

boolean

men and women locally advanced, metastastic and/or recurrent nsclc with adenocarcinoma histology for which vargatef treatment is indicated according to summary of product characteristics (smpc)
Description

ID.2

Type de données

boolean

after first line therapy; second-line therapy not yet started
Description

ID.3

Type de données

boolean

standard 21-day-cycles docetaxel treatment according to smpc possible
Description

ID.4

Type de données

boolean

written informed consent
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications according to the smpc of vargatef or docetaxel
Description

ID.6

Type de données

boolean

more than one systemic therapy for treatment of nsclc in palliative setting
Description

ID.7

Type de données

boolean

current partcipation in another non-interventional study or a clinical trial
Description

ID.8

Type de données

boolean

pregnancy
Description

ID.9

Type de données

boolean

breastfeeding
Description

ID.10

Type de données

boolean

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age 18 or older
boolean
ID.2
Item
men and women locally advanced, metastastic and/or recurrent nsclc with adenocarcinoma histology for which vargatef treatment is indicated according to summary of product characteristics (smpc)
boolean
ID.3
Item
after first line therapy; second-line therapy not yet started
boolean
ID.4
Item
standard 21-day-cycles docetaxel treatment according to smpc possible
boolean
ID.5
Item
written informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
contraindications according to the smpc of vargatef or docetaxel
boolean
ID.7
Item
more than one systemic therapy for treatment of nsclc in palliative setting
boolean
ID.8
Item
current partcipation in another non-interventional study or a clinical trial
boolean
ID.9
Item
pregnancy
boolean
ID.10
Item
breastfeeding
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial